Xenon Pharmaceuticals
XENE
#3880
Rank
ยฃ1.74 B
Marketcap
ยฃ22.78
Share price
-4.27%
Change (1 day)
-30.20%
Change (1 year)

Revenue for Xenon Pharmaceuticals (XENE)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xenon Pharmaceuticals from 2014 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A-100%
2022 ยฃ7.79 M-42.91%
2021 ยฃ13.65 M-42.12%
2020 ยฃ23.59 M353.13%
2019 ยฃ5.2 M
2018 N/A-100%
2017 ยฃ0.23 M-84.25%
2016 ยฃ1.46 M-86.1%
2015 ยฃ10.51 M-42.32%
2014 ยฃ18.22 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.20 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ99.92 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA